150 related articles for article (PubMed ID: 36046124)
21. Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.
Visvanathan K; Fackler MS; Zhang Z; Lopez-Bujanda ZA; Jeter SC; Sokoll LJ; Garrett-Mayer E; Cope LM; Umbricht CB; Euhus DM; Forero A; Storniolo AM; Nanda R; Lin NU; Carey LA; Ingle JN; Sukumar S; Wolff AC
J Clin Oncol; 2017 Mar; 35(7):751-758. PubMed ID: 27870562
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis.
Parisi C; Mastoraki S; Markou A; Strati A; Chimonidou M; Georgoulias V; Lianidou ES
Clin Chim Acta; 2016 Oct; 461():156-64. PubMed ID: 27510924
[TBL] [Abstract][Full Text] [Related]
23. Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation.
Hentschel AE; Beijert IJ; Bosschieter J; Kauer PC; Vis AN; Lissenberg-Witte BI; van Moorselaar RJA; Steenbergen RDM; Nieuwenhuijzen JA
Clin Epigenetics; 2022 Feb; 14(1):19. PubMed ID: 35123558
[TBL] [Abstract][Full Text] [Related]
24. In Situ Detection of Plasma Exosomal MicroRNA-1246 for Breast Cancer Diagnostics by a Au Nanoflare Probe.
Zhai LY; Li MX; Pan WL; Chen Y; Li MM; Pang JX; Zheng L; Chen JX; Duan WJ
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39478-39486. PubMed ID: 30350935
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.
Pedersen SK; Symonds EL; Baker RT; Murray DH; McEvoy A; Van Doorn SC; Mundt MW; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Dekker E; Young GP
BMC Cancer; 2015 Oct; 15():654. PubMed ID: 26445409
[TBL] [Abstract][Full Text] [Related]
26. A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.
Dimitrakopoulos L; Vorkas PA; Georgoulias V; Lianidou ES
BMC Cancer; 2012 Oct; 12():486. PubMed ID: 23088560
[TBL] [Abstract][Full Text] [Related]
27. A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancer.
Deng L; Chao H; Deng H; Yu Z; Zhao R; Huang L; Gong Y; Zhu Y; Wang Q; Li F; Liu L; He L; Tang Z; Liao C; Qi Y; Wang X; Zeng T; Zou H
BMC Cancer; 2022 May; 22(1):510. PubMed ID: 35524222
[TBL] [Abstract][Full Text] [Related]
28. Development and initial clinical correlation of a DNA methylation-based blood test for prostate cancer.
Carson JJK; Di Lena MA; Berman DM; Siemens DR; Mueller CR
Prostate; 2020 Sep; 80(12):1038-1042. PubMed ID: 32506642
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
[TBL] [Abstract][Full Text] [Related]
30. Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence.
Xie H; Mahoney DW; Foote PH; Burger KN; Doering KA; Taylor WR; Then SS; Cao X; McGlinch M; Berger CK; Wu TT; Hubbard JM; Allawi HT; Kaiser MW; Lidgard GP; Ahlquist DA; Kisiel JB
Clin Cancer Res; 2021 Jan; 27(1):141-149. PubMed ID: 33028593
[TBL] [Abstract][Full Text] [Related]
31. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
[TBL] [Abstract][Full Text] [Related]
32. Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer.
Keup C; Suryaprakash V; Hauch S; Storbeck M; Hahn P; Sprenger-Haussels M; Kolberg HC; Tewes M; Hoffmann O; Kimmig R; Kasimir-Bauer S
Genome Med; 2021 May; 13(1):85. PubMed ID: 34001236
[TBL] [Abstract][Full Text] [Related]
33. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPD.
Wielscher M; Vierlinger K; Kegler U; Ziesche R; Gsur A; Weinhäusel A
EBioMedicine; 2015 Aug; 2(8):929-36. PubMed ID: 26425700
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer.
Liu J; Zhao H; Huang Y; Xu S; Zhou Y; Zhang W; Li J; Ming Y; Wang X; Zhao S; Li K; Dong X; Ma Y; Qian T; Chen X; Xing Z; Zhang Y; Chen H; Liu Z; Pang D; Zhou M; Wu Z; Wang X; Wang X; Wu N; Su J
Mol Cancer; 2021 Feb; 20(1):36. PubMed ID: 33608029
[TBL] [Abstract][Full Text] [Related]
36. Development and performance evaluation of TaqMan real-time fluorescence quantitative methylation specific PCR for detecting methylation level of PER2.
Jiang H; Yang X; Mi M; Wei X; Wu H; Xin Y; Jiao L; Sun S; Sun C
Mol Biol Rep; 2022 Mar; 49(3):2097-2105. PubMed ID: 34854010
[TBL] [Abstract][Full Text] [Related]
37. The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients.
Van der Auwera I; Elst HJ; Van Laere SJ; Maes H; Huget P; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Br J Cancer; 2009 Apr; 100(8):1277-86. PubMed ID: 19367284
[TBL] [Abstract][Full Text] [Related]
38. The potential of ctDNA analysis in breast cancer.
Tzanikou E; Lianidou E
Crit Rev Clin Lab Sci; 2020 Jan; 57(1):54-72. PubMed ID: 31674269
[TBL] [Abstract][Full Text] [Related]
39. [Current situation and prospect of breast cancer liquid biopsy].
Zhou B; Xin L; Xu L; Ye JM; Liu YH
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):106-109. PubMed ID: 29397622
[TBL] [Abstract][Full Text] [Related]
40. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
Zhang X; Ju S; Wang X; Cong H
Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
